Approved Projects
Here you can browse the complete list of projects on CDAS whose requests for data/biospecimens were approved.
| Name | Principal Investigator | Institution | Study | Date Approved | Project ID |
|---|---|---|---|---|---|
| Machine Learning Model to Predict Various Types of Cancer | Bence Lukacsy | Barrington High School | PLCO | Dec 5, 2022 | PLCO-1112 |
| Machine learning to differentiate between malignant and benign nodules | Parag Chaudhari | Mon Health Medical Center | NLST | Jun 22, 2017 | NLST-315 |
| Machine Learning to identify airway disease | Amir Sharafkhaneh | Baylor College of Medicine | NLST | Jun 13, 2022 | NLST-921 |
| Machine learning to identify, track, and monitor disease | John MacLean | doclink.io | NLST | Aug 16, 2017 | NLST-338 |
| Machine learning to predict risk from chest radiographs and clinical factors | Michael Lu | The General Hospital Corporation d/b/a Massachusetts General Hospital | NLST | Dec 29, 2017 | NLST-383 |
| Machine learning to predict risk from chest radiographs and clinical factors | Michael Lu | The General Hospital Corporation d/b/a Massachusetts General Hospital | PLCO | Dec 19, 2017 | PLCO-331 |
| Machine Learning to select patients benefiting from prostate cancer screening | Jean-Emmanuel Bibault | Laboratory of Artificial Intelligence in Medicine and Biomedical Physics, Stanford University | PLCO | Oct 24, 2019 | PLCO-541 |
| Machine Learning with Low Dose CT Data | Bennett Landman | Vanderbilt University | NLST | Dec 8, 2022 | NLST-993 |
| Maestro | Anouk Stein | MD.ai | NLST | Jan 2, 2019 | NLST-463 |
| Magnesium intake and bladder cancer incidence and mortality in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial | Shengyin He | Sichuan University | PLCO | Feb 17, 2021 | PLCO-736 |
| Magnesium intake and colorectal cancer incidence and mortality in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial | Zhuyue Li | Sichuan University | PLCO | Nov 17, 2020 | PLCO-692 |
| Magnesium intake and primary liver cancer incidence and mortality in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial | Guo-Chao Zhong | The Second Affiliated Hospital of Chongqing Medical University | PLCO | Dec 11, 2019 | PLCO-559 |
| Male pattern baldness and prostate cancer risk: a prospective study in PLCO | Michael Cook | NCI, DCEG, HREB | PLCO | Oct 6, 2011 | 2011-0231 |
| Male pattern baldness and risk of mortality and cancer outcomes | Wen-Yi Huang | National Cancer Institute, NIH | PLCO | Aug 29, 2016 | PLCO-223 |
| Male pattern baldness: is there an association with bladder cancer? | Badrinath Konety | University of Minnesota | PLCO | Jan 18, 2018 | PLCO-340 |
| Malignant risk prediction model was constructed based on image omics. | YUE LI | Guang'anmen Hospital, China Academy of Chinese Medical Sciences | NLST | Sep 5, 2023 | NLST-1117 |
| Managing Multi-Center Recruitment in the PLCO Cancer Screening Trial | Pam Marcus | NCI | PLCO | Sep 16, 2015 | PLCO-159 |
| Mapping the progression of COPD to Lung Cancer | Tej Pandya | Francis Crick Institute | PLCO | Dec 4, 2023 | PLCO-1401 |
| Marital status and all cause and cause-specific mortality in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. | danhua wang | Department of Public Health and Preventive Medicine, Kangda College of Nanjing Medical University | PLCO | Jul 2, 2021 | PLCO-804 |
| Marker Discovery and Prognostic Modeling in Prostate Cancer to Identify Optimal Therapy and Intervention. | sumit maan | Indian Institute of Technology, Mandi | PLCO | Jun 24, 2024 | PLCOI-1594 |